Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:131 Issue:1 Number:2 ISSN#:2564-2537
DOWNLOAD ESPAÑOL
RCT
ACE Report #14082
Ace Report Cover Osteoarthritis

Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis


How to Cite

OrthoEvidence. Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis. ACE Report. 2021;131(1):2. Available from: https://myorthoevidence.com/AceReport/Report/14082

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

The Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis: A Randomized Active-Controlled Clinical Trial

Evid Based Complement Alternat Med. 2021; 2021: 5596892.

Contributing Authors: HR Farpour N Rajabi B Ebrahimi

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Thirty-eight patients with knee osteoarthritis were randomized to receive 1 month of Harpagophytum procumbens treatment (n=18) or 10 days of daily meloxicam (n=20). Outcomes of interest included pain on a Visual Analog Scale (VAS), the Oxford Knee Scale (OKS) score, and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) score. Outcomes were assessed at 2, 4 and 8 weeks follow up...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.